Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025

Nov 18, 2025 - 05:00

1

Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025

Related Posts

ZipRecruiter president David Travers sells $106,161 in stock

ZipRecruiter president David Travers sells $106,161 in ...

Mar 21, 2025 1

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

ZipRecruiter CEO Ian Siegel sells shares worth $269,639

Mar 21, 2025 0

Businesses may have to pass high beef prices on to consumers

Businesses may have to pass high beef prices on to cons...

Mar 21, 2025 0

Meta global affairs chief says decision not to offer Instagram, Facebook in China helps defend free expression

Meta global affairs chief says decision not to offer In...

Mar 21, 2025 3

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025 4

Elon Musk reassures Tesla workers with all-hands meeting, admits it 'feels like Armageddon'

Elon Musk reassures Tesla workers with all-hands meetin...

Mar 21, 2025 3